BofA raised the firm’s price target on Veeva to $220 from $200 and keeps a Neutral rating on the shares. The company’s Q2 results and outlook were overall “healthy,” the analyst tells investors. The firm, however, sees few near term catalysts for free-cash-flow upside and believes near-term upside is largely price in.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VEEV:
- Veeva Systems (NYSE:VEEV): Here’s How Analysts Reacted to the Stock After Q2 Results
- Veeva price target raised to $211 from $205 at Stifel
- Veeva price target raised to $240 from $210 at Raymond James
- Veeva price target raised to $235 from $232 at Piper Sandler
- Veeva price target raised to $205 from $175 at UBS